Triazolam (or HALCION®) is mainly prescribed to treat insomnia.
FDA Approval: 1982
Dosage Forms: .125 mg, .25 mg
Biological Half-life: 1.5-5.5 hours
Side Effects: Dizziness, sleepiness, blurred vision, poor concentration, amnesia, slurred speech, lack of coordination
Serious Risks: Should NOT be taken during pregnancy
Routes of Administration: Oral
Pregnancy Category: X (US)